 |
|
|
|
 |
Classification of Acute Lymphoblastic Leukemia
[Protocol 06-023]
- Full Title :
- CLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA (COG-AALL03B1)
- Purpose :
Acute lymphoblastic leukemia (ALL) is a cancer of white blood cells called lymphocytes. Through this study, researchers want to refine the way doctors classify leukemia by analyzing bone marrow and blood samples from patients with ALL to find out exactly what type of leukemia they have and to learn more about what causes leukemia. The findings of this research will help doctors learn how to improve the treatment of leukemia in the future.
Bone marrow obtained from the patients at the time of diagnosis and during the initial (induction) phase of chemotherapy will be analyzed with respect to molecular, genetic, and other characteristics. Researchers hope to identify certain features that may predict how well a patient is likely to respond to therapy and clarify which course of therapy would be most effective for each patient.
Participants in this clinical trial will include children and young adults. This trial is part of a Children's Oncology Group study.
- Eligibility :
To be eligible for this study, patients must meet several criteria, including but not limited to the following:
- Patients must be newly diagnosed with acute leukemia that is suspected to be ALL.
- Patients may not have received prior chemotherapy for their leukemia.
- Patients must be under age 31.
For more information and to inquire about eligibility for this study, please contact Dr. Peter Steinherz at 212-639-7951.
|
|
|
|
|
